<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Drug and alcohol dependence</journal-title></journal-title-group><issn pub-type="ppub">0376-8716</issn><issn pub-type="epub">1879-0046</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10121859</article-id><article-id pub-id-type="pmcid-ver">PMC10121859.1</article-id><article-id pub-id-type="pmcaid">10121859</article-id><article-id pub-id-type="pmcaiid">10121859</article-id><article-id pub-id-type="manuscript-id">NIHMS1886866</article-id><article-id pub-id-type="pmid">36989708</article-id><article-id pub-id-type="doi">10.1016/j.drugalcdep.2023.109850</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1886866</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1886866</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Substance use severity as a predictor for receiving medication for opioid use disorder among adolescents: an analysis of the 2019 TEDS</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Welsh</surname><given-names initials="JW">Justine W.</given-names></name><degrees>M.D.</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sitar</surname><given-names initials="SI">Siara I.</given-names></name><degrees>M.S.</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hunter</surname><given-names initials="BD">Brooke D.</given-names></name><degrees>M.S.</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Godley</surname><given-names initials="MD">Mark D.</given-names></name><degrees>Ph,D.</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dennis</surname><given-names initials="ML">Michael L.</given-names></name><degrees>Ph.D.</degrees><xref rid="A2" ref-type="aff">b</xref></contrib></contrib-group><aff id="A1"><label>a</label>Department of Psychiatry and Behavioral Services, Emory University School of Medicine, 1821 Clifton Drive NE, Atlanta, GA 30329, USA</aff><aff id="A2"><label>b</label>Chestnut Health Systems, 448 Wylie Drive, Normal, IL 61761, USA.</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Contributors</p><p id="P2">Justine W. Welsh has contributed to the conceptualization, methodology, writing, reviewing, editing, supervision, and project administration for this manuscript.</p><p id="P3">Siara I. Sitar has contributed to the conceptualization, methodology, writing, reviewing, editing, visualization, and project administration for this manuscript.</p><p id="P4">Brooke D. Hunter has contributed to the conceptualization, methodology, formal analysis, writing, and editing for this manuscript.</p><p id="P5">Mark D. Godley has contributed to the conceptualization, methodology, editing, reviewing, and supervision for this manuscript.</p><p id="P6">Michael L. Dennis has contributed to the conceptualization, methodology, editing, reviewing, and supervision for this manuscript.</p><p id="P7">All authors have approved the final manuscript.</p></fn><corresp id="CR1"><bold>Corresponding Author:</bold> Dr. Justine Welsh, MD, 12 Executive Park Drive NE, Atlanta, GA 30329, USA, <email>Justine.Welsh@emory.edu</email>, Phone: 404-778-5526, Fax: 404-727-3421</corresp><fn fn-type="COI-statement" id="FN9"><p id="P33">Conflict of Interest</p><p id="P34">Dr. Welsh has received consulting fees received from Applied Clinical Intelligence LLC (ACI Clinical). Ms. Sitar, Ms. Hunter, Dr. Godley, and Dr. Dennis have no disclosures to report.</p></fn></author-notes><pub-date pub-type="epub"><day>23</day><month>3</month><year>2023</year></pub-date><volume>246</volume><issue-id pub-id-type="pmc-issue-id">434055</issue-id><fpage>109850</fpage><lpage>109850</lpage><pub-history><event event-type="nihms-submitted"><date><day>30</day><month>03</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 11:25:31.053"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1886866.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P8">Medication for opioid use disorder (MOUD) is vastly underutilized in adolescents. Existing treatment guidelines for OUD largely focus on adults, providing limited guidance for pediatric populations. Limited information is known about use of MOUD in adolescents based on substance use severity.</p></sec><sec id="S2"><title>Methods:</title><p id="P9">This secondary data analysis examined how patient-level variables influenced the receipt of MOUD in adolescents aged 12&#8211;17 (n = 1,866) using the Treatment Episode Data Set (TEDS) 2019 Discharge data set. A crosstabulation and chi-square statistic evaluated the relationship between a proxy for clinical need based on high-risk opioid use (either reporting daily opioid use within the past 30 days and/or history of injection opioid use) for MOUD in states with and without adolescents receiving MOUD (n = 1,071). A two-step logistic regression analysis in states with any adolescents receiving MOUD examined the explanatory power of demographic, treatment intake, and substance use characteristics.</p></sec><sec id="S3"><title>Results:</title><p id="P10">Completion of 12<sup>th</sup> grade, a GED, or beyond, decreased the likelihood of receiving MOUD (odds ratio [OR]= 0.38, <italic toggle="yes">p</italic> = 0.017), as did being female (OR = 0.47, <italic toggle="yes">p</italic> = .006). None of the remaining clinical criteria were significantly associated with MOUD, although a history of one or more arrests increased the likelihood of MOUD (OR = 6.98, <italic toggle="yes">p</italic> = 0.06). Only 13% of individuals who met criteria for clinical need received MOUD.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P11">Lower education could serve as a proxy for substance use severity. Guidelines and best practices are needed to ensure the proper distribution of MOUD to adolescents based on clinical need.</p></sec></abstract><kwd-group><kwd>Substance Use Disorder (SUD)</kwd><kwd>Medication for Opioid Use Disorder (MOUD)</kwd><kwd>Adolescents</kwd><kwd>Disparities</kwd><kwd>Substance Use Treatment</kwd><kwd>Clinicians</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>